Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price: 59.74
Bid: 59.64
Ask: 59.76
Change: -0.94 (-1.55%)
Spread: 0.12 (0.20%)
Open: 61.56
High: 61.56
Low: 59.66
Yest. Close: 60.68
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

Indivior PLC - Indivior to Participate in Conference

Thu, 16th May 2019 07:00

RNS Number : 1647Z
Indivior PLC
16 May 2019
 

Indivior to Participate in Jefferies 2019 Healthcare Conference

 

Slough, UK and Richmond, VA - May 16, 2019 - Indivior PLC (LON: INDV) today announced that Shaun Thaxter, Chief Executive Officer, and Mark Crossley, Chief Financial Officer, will participate in Jefferies 2019 Healthcare Conference taking place in New York City on June 4 to 7, 2019.

 

On Tuesday, June 4th at 10:30 a.m. EST, Thaxter will discuss Indivior's strategy and outlook. His remarks will be webcast live and the broadcast will be available on the "Investors" section of Indivior's website (www.indivior.com) under "Webcasts / Audiocasts / Presentations." If you plan to listen to the live webcast, please allow sufficient time to register and download any audio software required to access the discussion.

 

 

About Indivior

Indivior is a global specialty pharmaceutical company working to change patient lives by pioneering life-transforming treatment for addiction and other serious mental health diseases. Our Vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of opioid dependence treatments, Indivior has a strong pipeline of product candidates designed to both expand on its heritage in this category and address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder and schizophrenia. Headquartered in the United States in Richmond, VA, Indivior employs more than 800 individuals globally and its portfolio of products is available in over 40 countries worldwide. Visit www.indivior.com to learn more.

 

Contact:

Jason Thompson

804-402-7123

Vice President, Investor Relations

jason.thompson@indivior.com

 

###

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEASSSFDFNEFF
Date   Source Headline
13th Aug 20192:30 pmRNSIndivior PLC - Director/PDMR Shareholding
9th Aug 20197:00 amRNSIndivior PLC - Director/PDMR Shareholding
8th Aug 20192:30 pmRNSIndivior PLC - Director/PDMR Shareholding
6th Aug 20192:00 pmRNSIndivior PLC - Director/PDMR Shareholding
1st Aug 20193:37 pmRNSIndivior PLC - Holding(s) in Company

Login to your account

Don't have an account? Click here to register.